NanoVation-GS is a med-tech startup aiming to help alleviate the suffering of hundreds of millions of patients and reduce the high financial burden due to frequent hospitalizations of chronic respiratory patients such as COPD and asthma. SenseGuard™, developed by NanoVation-GS, is a reliable and patient-friendly solution for monitoring patients’ respiratory condition, measuring unique lung function biomarkers from effortless (tidal) breathing. Short measurements of 2-3 minutes once a day, enable disease management and early detection and treatment of exacerbations, before they reach acute stage that requires hospitalization.